Wyszukaj badanie kliniczne
5 Wyniki
Badanie kliniczne z otwartą rekrutacją
= ; Badanie kliniczne w toku
=
; Terminated trial =
; Ufundowane przez członka IRDiRC =
; MISSING CONTENT =
Krajowe badania kliniczne

KANADA
Ontario
TORONTO
Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003)
The Hospital for Sick Children and University of Toronto
Department of Ophthalmology and Vision Science

FRANCJA
ILE-DE-FRANCE
PARIS

Traitement adjuvant dans les rétinoblastomes unilatéraux étendus énucléés d'emblée (Phase II)
CLCC Institut Curie
Département d'Oncologie pédiatrique, adolescents et jeunes adultes

HOLANDIA
Noord-Holland
AMSTERDAM
The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Maag-Darm-Leveroncologie

BELGIA
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Programme d'extension à long terme du Sorafénib - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

WŁOCHY
LAZIO
ROMA